- call +1-201-465-4211
- email sales@mrinsights.biz
Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area (local anesthetic). It is also used to treat ventricular tachycardia and to perform nerve blocks. Lidocaine mixed with a small amount of adrenaline (epinephrine) is available to allow larger doses for numbing, to decrease bleeding, and to make the numbing effect last longer. When used as an injectable, it typically begins working within four minutes and lasts for half an hour to three hours. Lidocaine mixtures may also be applied directly to the skin or mucous membranes to numb the area.
Scope of the Report:
This report focuses on the Lignocaine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Lignocaine is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive. The wholesale cost in the developing world in 2014 was US$0.45 to $1.05 wholesale per 20ml vial of medication.
The worldwide market for Lignocaine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Croma-Pharma
Cironpharma
Endo Pharmaceuticals
ESBA Laboratories
Sigma-Aldrich
Swati Spentose
Galen
Mahendra Chemicals
Iwaki Seiyaku
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Injectable
Topical
Inhalation
Market Segment by Applications, can be divided into
Local Anesthesia
Anti-Arrhythmic
Others
There are 15 Chapters to deeply display the global Lignocaine market.
Chapter 1, to describe Lignocaine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Lignocaine, with sales, revenue, and price of Lignocaine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Lignocaine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Lignocaine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Lignocaine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Lignocaine Introduction
1.2 Market Analysis by Type
1.2.1 Injectable
1.2.2 Topical
1.2.3 Inhalation
1.3 Market Analysis by Applications
1.3.1 Local Anesthesia
1.3.2 Anti-Arrhythmic
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Croma-Pharma
2.1.1 Business Overview
2.1.2 Lignocaine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Croma-Pharma Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cironpharma
2.2.1 Business Overview
2.2.2 Lignocaine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cironpharma Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Endo Pharmaceuticals
2.3.1 Business Overview
2.3.2 Lignocaine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Endo Pharmaceuticals Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 ESBA Laboratories
2.4.1 Business Overview
2.4.2 Lignocaine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ESBA Laboratories Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sigma-Aldrich
2.5.1 Business Overview
2.5.2 Lignocaine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sigma-Aldrich Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Swati Spentose
2.6.1 Business Overview
2.6.2 Lignocaine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Swati Spentose Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galen
2.7.1 Business Overview
2.7.2 Lignocaine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Galen Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mahendra Chemicals
2.8.1 Business Overview
2.8.2 Lignocaine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mahendra Chemicals Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Iwaki Seiyaku
2.9.1 Business Overview
2.9.2 Lignocaine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Iwaki Seiyaku Lignocaine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Lignocaine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Lignocaine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Lignocaine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Lignocaine Manufacturer Market Share in 2017
3.3.2 Top 6 Lignocaine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Lignocaine Market Analysis by Regions
4.1 Global Lignocaine Sales, Revenue and Market Share by Regions
4.1.1 Global Lignocaine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Lignocaine Revenue and Market Share by Regions (2013-2018)
4.2 North America Lignocaine Sales and Growth Rate (2013-2018)
4.3 Europe Lignocaine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Lignocaine Sales and Growth Rate (2013-2018)
4.5 South America Lignocaine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Lignocaine Sales and Growth Rate (2013-2018)
5 North America Lignocaine by Countries
5.1 North America Lignocaine Sales, Revenue and Market Share by Countries
5.1.1 North America Lignocaine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Lignocaine Revenue and Market Share by Countries (2013-2018)
5.2 United States Lignocaine Sales and Growth Rate (2013-2018)
5.3 Canada Lignocaine Sales and Growth Rate (2013-2018)
5.4 Mexico Lignocaine Sales and Growth Rate (2013-2018)
6 Europe Lignocaine by Countries
6.1 Europe Lignocaine Sales, Revenue and Market Share by Countries
6.1.1 Europe Lignocaine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Lignocaine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Lignocaine Sales and Growth Rate (2013-2018)
6.3 UK Lignocaine Sales and Growth Rate (2013-2018)
6.4 France Lignocaine Sales and Growth Rate (2013-2018)
6.5 Russia Lignocaine Sales and Growth Rate (2013-2018)
6.6 Italy Lignocaine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Lignocaine by Countries
7.1 Asia-Pacific Lignocaine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Lignocaine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Lignocaine Revenue and Market Share by Countries (2013-2018)
7.2 China Lignocaine Sales and Growth Rate (2013-2018)
7.3 Japan Lignocaine Sales and Growth Rate (2013-2018)
7.4 Korea Lignocaine Sales and Growth Rate (2013-2018)
7.5 India Lignocaine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Lignocaine Sales and Growth Rate (2013-2018)
8 South America Lignocaine by Countries
8.1 South America Lignocaine Sales, Revenue and Market Share by Countries
8.1.1 South America Lignocaine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Lignocaine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Lignocaine Sales and Growth Rate (2013-2018)
8.3 Argentina Lignocaine Sales and Growth Rate (2013-2018)
8.4 Colombia Lignocaine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Lignocaine by Countries
9.1 Middle East and Africa Lignocaine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Lignocaine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Lignocaine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Lignocaine Sales and Growth Rate (2013-2018)
9.3 UAE Lignocaine Sales and Growth Rate (2013-2018)
9.4 Egypt Lignocaine Sales and Growth Rate (2013-2018)
9.5 Nigeria Lignocaine Sales and Growth Rate (2013-2018)
9.6 South Africa Lignocaine Sales and Growth Rate (2013-2018)
10 Global Lignocaine Market Segment by Type
10.1 Global Lignocaine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Lignocaine Sales and Market Share by Type (2013-2018)
10.1.2 Global Lignocaine Revenue and Market Share by Type (2013-2018)
10.2 Injectable Sales Growth and Price
10.2.1 Global Injectable Sales Growth (2013-2018)
10.2.2 Global Injectable Price (2013-2018)
10.3 Topical Sales Growth and Price
10.3.1 Global Topical Sales Growth (2013-2018)
10.3.2 Global Topical Price (2013-2018)
10.4 Inhalation Sales Growth and Price
10.4.1 Global Inhalation Sales Growth (2013-2018)
10.4.2 Global Inhalation Price (2013-2018)
11 Global Lignocaine Market Segment by Application
11.1 Global Lignocaine Sales Market Share by Application (2013-2018)
11.2 Local Anesthesia Sales Growth (2013-2018)
11.3 Anti-Arrhythmic Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Lignocaine Market Forecast (2018-2023)
12.1 Global Lignocaine Sales, Revenue and Growth Rate (2018-2023)
12.2 Lignocaine Market Forecast by Regions (2018-2023)
12.2.1 North America Lignocaine Market Forecast (2018-2023)
12.2.2 Europe Lignocaine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Lignocaine Market Forecast (2018-2023)
12.2.4 South America Lignocaine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Lignocaine Market Forecast (2018-2023)
12.3 Lignocaine Market Forecast by Type (2018-2023)
12.3.1 Global Lignocaine Sales Forecast by Type (2018-2023)
12.3.2 Global Lignocaine Market Share Forecast by Type (2018-2023)
12.4 Lignocaine Market Forecast by Application (2018-2023)
12.4.1 Global Lignocaine Sales Forecast by Application (2018-2023)
12.4.2 Global Lignocaine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Lignocaine Picture
Table Product Specifications of Lignocaine
Figure Global Sales Market Share of Lignocaine by Types in 2017
Table Lignocaine Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
